Merck Announces Positive Data for V116, an Investigational, 21-Valent Pneumococcal Conjugate Vaccine Specifically Designed for Adults

View Full Size 

Download

• Full Size JPEG, 3056x1380, 206.4 KB
• Small JPEG, 480x217, 23.7 KB
• Preview JPEG, 144x65, 5.6 KB
• Thumbnail JPEG, 120x54, 4.9 KB